trans-Nerolidol

Overview

trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) ( HY-15142A ) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo.

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Fungal

Product Information

• Catalog No.: HY-N6635
• CAS No.: 40716-66-3
• Molecular Formula: C15H26O
• Molecular Weight: 222.37
• Purity: 96.73%
• Storage: 4°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (11.24 mM); Clear solution
• Availability: In-stock

Source

Original product source